MXPA01013450A - Transferencia citoplasmica para celulas receptoras de-diferenciacion. - Google Patents
Transferencia citoplasmica para celulas receptoras de-diferenciacion.Info
- Publication number
- MXPA01013450A MXPA01013450A MXPA01013450A MXPA01013450A MXPA01013450A MX PA01013450 A MXPA01013450 A MX PA01013450A MX PA01013450 A MXPA01013450 A MX PA01013450A MX PA01013450 A MXPA01013450 A MX PA01013450A MX PA01013450 A MXPA01013450 A MX PA01013450A
- Authority
- MX
- Mexico
- Prior art keywords
- differentiate
- recipient cells
- cytoplasmic transfer
- cytoplasmic
- transfer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases (EC 2.)
- C12N2501/727—Kinases (EC 2.7.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/04—Immortalised cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2517/00—Cells related to new breeds of animals
- C12N2517/10—Conditioning of cells for in vitro fecondation or nuclear transfer
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14125099P | 1999-06-30 | 1999-06-30 | |
PCT/US2000/018063 WO2001000650A1 (en) | 1999-06-30 | 2000-06-30 | Cytoplasmic transfer to de-differentiate recipient cells |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA01013450A true MXPA01013450A (es) | 2003-09-04 |
Family
ID=22494867
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA01013450A MXPA01013450A (es) | 1999-06-30 | 2000-06-30 | Transferencia citoplasmica para celulas receptoras de-diferenciacion. |
Country Status (11)
Country | Link |
---|---|
US (4) | US20020001842A1 (es) |
EP (1) | EP1196426A4 (es) |
JP (1) | JP2003503071A (es) |
CN (1) | CN1362965A (es) |
AU (1) | AU782286B2 (es) |
BR (1) | BR0012099A (es) |
CA (1) | CA2377515C (es) |
IL (2) | IL147179A0 (es) |
MX (1) | MXPA01013450A (es) |
NZ (1) | NZ516236A (es) |
WO (1) | WO2001000650A1 (es) |
Families Citing this family (75)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1197699A (en) | 1997-10-23 | 1999-05-10 | Geron Corporation | Methods and materials for the growth of primate-derived primordial stem cells |
US6667176B1 (en) | 2000-01-11 | 2003-12-23 | Geron Corporation | cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells |
US7410798B2 (en) | 2001-01-10 | 2008-08-12 | Geron Corporation | Culture system for rapid expansion of human embryonic stem cells |
MXPA01013450A (es) | 1999-06-30 | 2003-09-04 | Advanced Cell Tech Inc | Transferencia citoplasmica para celulas receptoras de-diferenciacion. |
JP2003508079A (ja) * | 1999-09-07 | 2003-03-04 | アドバンスド セル テクノロジー、インコーポレイテッド | 老年期体細胞からクローン化された動物中の細胞寿命のテロメア回復と延長 |
US7820878B2 (en) * | 1999-11-19 | 2010-10-26 | Kyowa Hakko Kirin Co., Ltd. | Production of ungulates, preferably bovines that produce human immunoglobulins |
AU1777301A (en) * | 1999-11-19 | 2001-05-30 | Hematech, Llc | Production of ungulates, preferably bovines that produce human immunoglobulins |
US7074983B2 (en) * | 1999-11-19 | 2006-07-11 | Kirin Beer Kabushiki Kaisha | Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin |
US7414170B2 (en) * | 1999-11-19 | 2008-08-19 | Kirin Beer Kabushiki Kaisha | Transgenic bovines capable of human antibody production |
US20050042749A1 (en) | 2001-05-16 | 2005-02-24 | Carpenter Melissa K. | Dopaminergic neurons and proliferation-competent precursor cells for treating Parkinson's disease |
AU6319901A (en) | 2000-05-17 | 2001-11-26 | Geron Corp | Neural progenitor cell populations |
US7491534B2 (en) * | 2000-12-22 | 2009-02-17 | Kirin Holdings Kabushiki Kaisha | Methods for altering cell fate to generate T-cells specific for an antigen of interest |
KR100832943B1 (ko) * | 2000-12-22 | 2008-05-27 | 기린 파마 가부시끼가이샤 | 재구성된 공여체 염색질 또는 공여체 세포를 이용한 포유류의 클로닝방법 |
US20020142397A1 (en) | 2000-12-22 | 2002-10-03 | Philippe Collas | Methods for altering cell fate |
US7265262B2 (en) | 2001-03-21 | 2007-09-04 | Roslin Institute (Edinburgh) | Telomerizing nuclear donor cells and improving the efficiency on nuclear transfer |
WO2002079457A1 (en) | 2001-03-29 | 2002-10-10 | Ixion Biotechnology, Inc. | Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway |
GB0118984D0 (en) * | 2001-08-03 | 2001-09-26 | Intercytex Ltd | Fusion of cells |
MXPA04001725A (es) * | 2001-08-24 | 2005-04-11 | Advanced Cell Tech Inc | ANáLISIS DE SELECCION PARA IDENTIFICAR AGENTES INDUCTORES DE DIFERENCIACION Y PRODUCCION DE CELULAS DIFERENCIADAS PARA TERAPIA CELULAR. |
WO2003018780A1 (en) * | 2001-08-27 | 2003-03-06 | Advanced Cell Technology, Inc. | De-differentiation and re-differentiation of somatic cells and production of cells for cell therapies |
AU2002365162A1 (en) | 2001-11-14 | 2003-07-09 | Northwestern University | Self-assembly and mineralization of peptide-amphiphile nanofibers |
US7371719B2 (en) | 2002-02-15 | 2008-05-13 | Northwestern University | Self-assembly of peptide-amphiphile nanofibers under physiological conditions |
US7462448B2 (en) | 2002-08-02 | 2008-12-09 | Stratatech Corporation | Species specific DNA detection |
EP1391503A1 (en) * | 2002-08-12 | 2004-02-25 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | A method of cell re-programming by cytoplasmic transfer |
US7534761B1 (en) | 2002-08-21 | 2009-05-19 | North Western University | Charged peptide-amphiphile solutions and self-assembled peptide nanofiber networks formed therefrom |
AU2003290689A1 (en) * | 2002-11-08 | 2004-06-03 | Kyowa Hakko Kirin Co., Ltd. | Transgenic ungulates having reduced prion protein activity and uses thereof |
US7554021B2 (en) | 2002-11-12 | 2009-06-30 | Northwestern University | Composition and method for self-assembly and mineralization of peptide amphiphiles |
WO2004046167A2 (en) | 2002-11-14 | 2004-06-03 | Northwestern University | Synthesis and self-assembly of abc triblock bola peptide |
WO2004072104A2 (en) | 2003-02-11 | 2004-08-26 | Northwestern University | Methods and materials for nanocrystalline surface coatings and attachment of peptide amphiphile nanofibers thereon |
EP1620546A2 (en) * | 2003-04-21 | 2006-02-01 | The University of Massachusetts | Reprogramming nuclear function with somatic cell cytoplasm |
US7683236B2 (en) * | 2003-06-10 | 2010-03-23 | Trustees Of The University Of Pennsylvania | Enhanced production of cloned mammals by zona pellucida-free homologous mammalian embryo aggregation |
GB0316089D0 (en) * | 2003-07-09 | 2003-08-13 | Xo Bioscience Ltd | Differentiation method |
US7823789B2 (en) | 2004-12-21 | 2010-11-02 | Cognex Technology And Investment Corporation | Low profile illumination for direct part mark readers |
FR2861997A1 (fr) * | 2003-11-06 | 2005-05-13 | Fred Zacouto | Stimulateur cardiaque orthorythmique inotrope |
JP4851939B2 (ja) | 2003-12-05 | 2012-01-11 | ノースウエスタン ユニバーシティ | 自己−集合性ペプチド両親媒性物質および増殖因子送達のための関連する方法 |
US7452679B2 (en) | 2003-12-05 | 2008-11-18 | Northwestern University | Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof |
US20050214257A1 (en) | 2003-12-23 | 2005-09-29 | Northwestern University | Compositions and methods for controlling stem cell and tumor cell differentiation, growth, and formation |
NZ550106A (en) | 2004-04-22 | 2009-06-26 | Kyowa Hakko Kirin Co Ltd | Transgenic animals and uses thereof |
KR20070108555A (ko) | 2005-03-04 | 2007-11-12 | 노오쓰웨스턴 유니버시티 | 혈관신생 헤파린 결합 펩티드 양친매성 화합물 |
FR2885368A1 (fr) * | 2005-05-04 | 2006-11-10 | Fred Zacouto | Systemes et procedes de regeneration cellulaire et utilisations de telles cellules regenerees |
WO2007026255A2 (en) * | 2005-06-22 | 2007-03-08 | Universitetet I Oslo | Dedifferentiated cells and methods of making and using dedifferentiated cells |
ES2836764T3 (es) | 2005-08-03 | 2021-06-28 | Astellas Inst For Regenerative Medicine | Métodos mejorados de reprogramación de células somáticas animales |
US20070087437A1 (en) * | 2005-10-14 | 2007-04-19 | Jifan Hu | Methods for rejuvenating cells in vitro and in vivo |
US8114843B2 (en) * | 2005-11-18 | 2012-02-14 | The Regents Of The University Of California | Photoreactive regulator of protein function and methods of use thereof |
WO2008103462A2 (en) | 2007-02-23 | 2008-08-28 | Advanced Cell Technology, Inc. | Highly efficient methods for reprogramming differentiated cells and for generating animals and embryonic stem cells from reprogrammed cells |
US8076295B2 (en) | 2007-04-17 | 2011-12-13 | Nanotope, Inc. | Peptide amphiphiles having improved solubility and methods of using same |
JP2009024027A (ja) * | 2008-09-16 | 2009-02-05 | Tadashi Goino | 生理活性組成物 |
WO2010084275A1 (fr) * | 2009-01-26 | 2010-07-29 | Fred Zacouto | Procédé simplifié de reprogrammation génétique et épigénétique partielle de cellules. |
CN101798569B (zh) * | 2009-02-09 | 2012-11-21 | 北京瑞途之星科技有限公司 | 以卵裂后的发育胚胎替代卵母细胞的治疗性克隆新方法 |
JP2012523463A (ja) | 2009-04-13 | 2012-10-04 | ノースウエスタン ユニバーシティ | 軟骨再生のための新規なペプチドベースの足場およびその使用方法 |
EP3578205A1 (en) | 2010-08-06 | 2019-12-11 | ModernaTX, Inc. | A pharmaceutical formulation comprising engineered nucleic acids and medical use thereof |
CA3162352A1 (en) | 2010-10-01 | 2012-04-05 | Modernatx, Inc. | Modified nucleosides, nucleotides, and nucleic acids, and uses thereof |
CA2814860C (en) | 2010-10-22 | 2020-08-25 | Biotime Inc. | Methods of modifying transcriptional regulatory networks in stem cells |
DE12722942T1 (de) | 2011-03-31 | 2021-09-30 | Modernatx, Inc. | Freisetzung und formulierung von manipulierten nukleinsäuren |
WO2013010045A1 (en) | 2011-07-12 | 2013-01-17 | Biotime Inc. | Novel methods and formulations for orthopedic cell therapy |
CN102266350A (zh) * | 2011-07-20 | 2011-12-07 | 黄必录 | 逆转干细胞衰老的方案 |
US9464124B2 (en) | 2011-09-12 | 2016-10-11 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
CN102321571A (zh) * | 2011-09-21 | 2012-01-18 | 王跃嗣 | 从分化细胞制备自体造血干细胞的方法 |
PT3682905T (pt) | 2011-10-03 | 2022-04-07 | Modernatx Inc | Nucleósidos, nucleótidos e ácidos nucleicos modificados e respetivas utilizações |
LT2791160T (lt) | 2011-12-16 | 2022-06-10 | Modernatx, Inc. | Modifikuotos mrnr sudėtys |
US9303079B2 (en) | 2012-04-02 | 2016-04-05 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
US9572897B2 (en) | 2012-04-02 | 2017-02-21 | Modernatx, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
US9283287B2 (en) | 2012-04-02 | 2016-03-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of nuclear proteins |
CA2868996A1 (en) | 2012-04-02 | 2013-10-10 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of proteins |
PL2922554T3 (pl) | 2012-11-26 | 2022-06-20 | Modernatx, Inc. | Na zmodyfikowany na końcach |
US8980864B2 (en) | 2013-03-15 | 2015-03-17 | Moderna Therapeutics, Inc. | Compositions and methods of altering cholesterol levels |
EP3888640A1 (en) | 2013-06-05 | 2021-10-06 | AgeX Therapeutics, Inc. | Compositions and methods for induced tissue regeneration in mammalian species |
EP3052106A4 (en) | 2013-09-30 | 2017-07-19 | ModernaTX, Inc. | Polynucleotides encoding immune modulating polypeptides |
JP2016538829A (ja) | 2013-10-03 | 2016-12-15 | モデルナ セラピューティクス インコーポレイテッドModerna Therapeutics,Inc. | 低密度リポタンパク質受容体をコードするポリヌクレオチド |
US11078462B2 (en) | 2014-02-18 | 2021-08-03 | ReCyte Therapeutics, Inc. | Perivascular stromal cells from primate pluripotent stem cells |
US10240127B2 (en) | 2014-07-03 | 2019-03-26 | ReCyte Therapeutics, Inc. | Exosomes from clonal progenitor cells |
US9371516B2 (en) | 2014-09-19 | 2016-06-21 | Regenerative Medical Solutions, Inc. | Compositions and methods for differentiating stem cells into cell populations comprising beta-like cells |
US9828634B2 (en) | 2015-01-22 | 2017-11-28 | Regenerative Medical Solutions, Inc. | Markers for differentiation of stem cells into differentiated cell populations |
HUE054946T2 (hu) | 2015-03-23 | 2021-10-28 | Astellas Inst For Regenerative Medicine | Javított eljárás humán retinai pigment epitélium (RPE) sejtek és fotoreceptor progenitorok hatásosságának vizsgálatára |
CN106755113B (zh) * | 2016-12-29 | 2020-06-19 | 赛业(苏州)生物科技有限公司 | Es细胞基因打靶技术制备基因修饰小鼠的改进方法 |
WO2023038999A1 (en) * | 2021-09-07 | 2023-03-16 | Yuva Biosciences, Inc. | Compositions and methods for treating ovarian aging, ovarian diseases and conditions, and symptoms thereof |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6344526A (ja) * | 1986-08-12 | 1988-02-25 | Kingo Yoshida | 幼若細胞の細胞質・ミトコンドリア・イントロン他注入による若返り長寿法 |
US5480772A (en) | 1993-02-03 | 1996-01-02 | Brandeis University | In vitro activation of a nucleus |
US5830651A (en) | 1995-06-01 | 1998-11-03 | Signal Pharmaceuticals, Inc. | Human oligodendroglial progenitor cell line |
GB9517780D0 (en) * | 1995-08-31 | 1995-11-01 | Roslin Inst Edinburgh | Biological manipulation |
AU2593697A (en) | 1996-03-28 | 1997-10-17 | Albert Einstein College Of Medicine Of Yeshiva University | Transgenic organisms with altered telomerase activity |
IL128348A (en) * | 1996-08-19 | 2008-08-07 | Univ Massachusetts | Method of producing embryonic or stem like cell lines by transplantation of cell nuclei from animal or mammal, such cells and uses thereof |
US20010012513A1 (en) | 1996-08-19 | 2001-08-09 | University Of Massachusetts | Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
US6011197A (en) * | 1997-03-06 | 2000-01-04 | Infigen, Inc. | Method of cloning bovines using reprogrammed non-embryonic bovine cells |
WO1999005266A2 (en) * | 1997-07-26 | 1999-02-04 | Wisconsin Alumni Research Foundation | Trans-species nuclear transfer |
GB9809178D0 (en) | 1998-04-29 | 1998-07-01 | Univ Edinburgh | Nuclear reprogramming of somatic cells |
AU4487900A (en) * | 1999-04-23 | 2000-11-10 | Monica Palacios-Boyce | Microelectromechanical devices useful for manipulating cells or embryos, kits thereof, methods of making same, and methods of use thereof |
MXPA01013450A (es) | 1999-06-30 | 2003-09-04 | Advanced Cell Tech Inc | Transferencia citoplasmica para celulas receptoras de-diferenciacion. |
US20040199935A1 (en) | 1999-06-30 | 2004-10-07 | Chapman Karen B. | Cytoplasmic transfer to de-differentiate recipient cells |
NZ519346A (en) * | 1999-12-20 | 2004-02-27 | Univ Massachusetts | Embryonic or stem-like cells produced by cross species nuclear transplantation |
WO2003018780A1 (en) | 2001-08-27 | 2003-03-06 | Advanced Cell Technology, Inc. | De-differentiation and re-differentiation of somatic cells and production of cells for cell therapies |
-
2000
- 2000-06-30 MX MXPA01013450A patent/MXPA01013450A/es not_active Application Discontinuation
- 2000-06-30 WO PCT/US2000/018063 patent/WO2001000650A1/en active IP Right Grant
- 2000-06-30 AU AU59028/00A patent/AU782286B2/en not_active Ceased
- 2000-06-30 BR BR0012099-5A patent/BR0012099A/pt not_active IP Right Cessation
- 2000-06-30 IL IL14717900A patent/IL147179A0/xx unknown
- 2000-06-30 NZ NZ516236A patent/NZ516236A/xx not_active IP Right Cessation
- 2000-06-30 JP JP2001507057A patent/JP2003503071A/ja active Pending
- 2000-06-30 EP EP00945032A patent/EP1196426A4/en not_active Withdrawn
- 2000-06-30 CA CA2377515A patent/CA2377515C/en not_active Expired - Lifetime
- 2000-06-30 CN CN00809800A patent/CN1362965A/zh active Pending
- 2000-12-15 US US09/736,268 patent/US20020001842A1/en not_active Abandoned
-
2001
- 2001-12-19 IL IL147179A patent/IL147179A/en not_active IP Right Cessation
-
2012
- 2012-09-14 US US13/617,988 patent/US20130104253A1/en not_active Abandoned
-
2014
- 2014-06-11 US US14/302,384 patent/US9580683B2/en not_active Expired - Fee Related
-
2017
- 2017-02-17 US US15/436,545 patent/US20170226475A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2377515C (en) | 2013-09-03 |
BR0012099A (pt) | 2003-07-29 |
JP2003503071A (ja) | 2003-01-28 |
US20170226475A1 (en) | 2017-08-10 |
IL147179A (en) | 2015-01-29 |
AU5902800A (en) | 2001-01-31 |
NZ516236A (en) | 2004-12-24 |
EP1196426A4 (en) | 2003-09-03 |
CN1362965A (zh) | 2002-08-07 |
US9580683B2 (en) | 2017-02-28 |
EP1196426A1 (en) | 2002-04-17 |
WO2001000650A1 (en) | 2001-01-04 |
CA2377515A1 (en) | 2001-01-04 |
US20020001842A1 (en) | 2002-01-03 |
US20130104253A1 (en) | 2013-04-25 |
IL147179A0 (en) | 2002-08-14 |
US20150132853A1 (en) | 2015-05-14 |
AU782286B2 (en) | 2005-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA01013450A (es) | Transferencia citoplasmica para celulas receptoras de-diferenciacion. | |
MXPA01009973A (es) | Celda de electrolito solido. | |
AU2001252014A1 (en) | Photovoltaic cell | |
AU1292700A (en) | Immune cells having predefined biological specificity, comprising chimeric t cell receptor | |
AU2002368042A8 (en) | Photovoltaic cell | |
TW588694U (en) | Utility knife | |
TW592169U (en) | Utility knife | |
GB9819260D0 (en) | Solar cell arrangements | |
HK1048564A1 (zh) | 鋰電磁 | |
MXPA01002455A (es) | Celda de electrolito solido. | |
EP1333086A4 (en) | CELL CULTURE CONTAINER | |
GB9904905D0 (en) | Cells | |
MXPA01008811A (es) | Equipo mejorado para purificacion de agua. | |
MXPA02003570A (es) | Pasta de bateria. | |
AU2001252015A1 (en) | Photovoltaic cell | |
MXPA01011746A (es) | Transmisor tolerante a las variaciones del cristal. | |
AU1154802A (en) | Single cell electroporation | |
EP1521328A4 (en) | SOLAR CELL | |
IL152977A0 (en) | Electrolysis cell | |
SG86407A1 (en) | Regenerative tie-high tie-low cell | |
AUPQ520600A0 (en) | Improvements in electrolysis cells | |
ZA200000062B (en) | Improvements in or relating to packaging. | |
EP1128451A4 (en) | CELL | |
GB0229261D0 (en) | Cells,culture methods and their uses | |
IL149290A0 (en) | Medium for preparing dedifferentiated cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |